What's on the web on your pursuit, hobbies, interests and worries

GraftVersusHostDisease news

FDA approves treatment for chronic graft versus host disease


FDA.gov - Aug 2, 2017
The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more treatments. This is the first FDA-approved ...
 

Ocugen's treatment for ocular graft-versus-host disease gets orphan drug designation


Healio - Aug 9, 2017
This is the first orphan drug designation by the FDA for ocular graft-versus-host disease, Shankar Musunuri, PhD, MBA, Ocugen's chairman, CEO and co-founder, said in the release. He also said the company plans to advance the clinical development of ...
 

FDA approves chronic graft versus host disease treatment


UPI.com - Aug 4, 2017
3 (UPI) -- The U.S. Food and Drug Administration announced Wednesday it has approved a new treatment for adult patients with chronic graft versus host disease, or cGVHD. cGVHD is a life-threatening condition that occurs in patients after they receive a ...
 

Graft Versus Host Disease - premium items on eBay

Chronic Graft Versus Host Disease: Interdisciplinary Management by Georgia B Vog


 

Chronic Graft Versus Host Disease: Interdisciplinary Management


 

Atlas of Graft-versus-host Disease by Hardcover Book


 

>> Go to all great Graft Versus Host Disease deals on eBay


Graft Versus Host Disease pictures on the web

>> Show

Graft Versus Host Disease videos

Graft-Versus-Host Disease/Graft-Versus-Leukemia: Recent Advances in Therapy


\
 

Transplant Rejection - Hyperacute, Acute, Chronic & Graft versus Host Disease


http://usmlefasttrack.com/?p=5718 Transplant, Rejection, -, Hyperacute,, Acute,, Chronic, &, Graft, versus, Host, Disease, Findings, symptoms, findings, causes, ...
 

Graft versus host disease: how to treat it?


John Murray, clinical nurse at the Christie NHS Foundation Trust, Manchester, UK, discusses the highlights from the nurses session on graft versus host disease ...
 

Graft-Versus-Host Disease: Diagnostic and Therapeutic Advances


2013 Clinical Education Conference Daniel R Couriel, MD, University of Michigan.
 

David Miklos, MD, PhD: Ibrutinib in Chronic Graft-Versus-Host Disease


For patients who experience graft-versus-host disease after transplant and do not respond to corticosteroids, ibrutunib leads to a high, durable response rate, ...